However, these findings were challenged by the study of Han et al. [43], which showed that MALAT1 had a function as a tumor suppressor by attenuating the ERK/MAPK-mediated growth and MMP2-mediated invasiveness in glioma. Here, MMP2 is linked to central nervous system cancer.